BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28912377)

  • 1. Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission.
    Mould RC; van Vloten JP; AuYeung AWK; Karimi K; Bridle BW
    Endocr Relat Cancer; 2017 Dec; 24(12):T311-T329. PubMed ID: 28912377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Landscape of Thyroid Cancers: New Insights.
    Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
    Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemokine receptors in thyroid cancer and immunotherapy.
    Coperchini F; Croce L; Marinò M; Chiovato L; Rotondi M
    Endocr Relat Cancer; 2019 Aug; 26(8):R465-R478. PubMed ID: 31146261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and future immunotherapies for thyroid cancer.
    Antonelli A; Ferrari SM; Fallahi P
    Expert Rev Anticancer Ther; 2018 Feb; 18(2):149-159. PubMed ID: 29241377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging the immune system to treat advanced thyroid cancers.
    French JD; Bible K; Spitzweg C; Haugen BR; Ryder M
    Lancet Diabetes Endocrinol; 2017 Jun; 5(6):469-481. PubMed ID: 27773653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.
    French JD
    Nat Rev Endocrinol; 2020 Nov; 16(11):629-641. PubMed ID: 32839578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy and gene therapy of thyroid cancer.
    Schott M; Scherbaum WA
    Minerva Endocrinol; 2004 Dec; 29(4):175-87. PubMed ID: 15765027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translating the immune microenvironment of thyroid cancer into clinical practice.
    Cunha LL; Ward LS
    Endocr Relat Cancer; 2022 May; 29(6):R67-R83. PubMed ID: 35289765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies.
    Liotti F; Prevete N; Vecchio G; Melillo RM
    F1000Res; 2019; 8():. PubMed ID: 30854191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune and Inflammatory Cells in Thyroid Cancer Microenvironment.
    Ferrari SM; Fallahi P; Galdiero MR; Ruffilli I; Elia G; Ragusa F; Paparo SR; Patrizio A; Mazzi V; Varricchi G; Marone G; Antonelli A
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THERAPY OF ENDOCRINE DISEASE Immunotherapy of advanced thyroid cancer: from bench to bedside.
    Moretti S; Menicali E; Nucci N; Guzzetti M; Morelli S; Puxeddu E
    Eur J Endocrinol; 2020 Aug; 183(2):R41-R55. PubMed ID: 32449696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.
    Xi C; Zhang GQ; Sun ZK; Song HJ; Shen CT; Chen XY; Sun JW; Qiu ZL; Luo QY
    Front Immunol; 2020; 11():1124. PubMed ID: 32655554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of novel immunotherapy targeting cancer immune evasion].
    Tamada K
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1062-5. PubMed ID: 25248888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting immune-based therapies for aggressive follicular cell-derived thyroid cancers.
    French JD
    Thyroid; 2013 May; 23(5):529-42. PubMed ID: 23317509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological aspects of cancers arising from thyroid follicular cells.
    Baker JR; Fosso CK
    Endocr Rev; 1993 Dec; 14(6):729-46. PubMed ID: 8119235
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment of the hu-PBL-SCID mouse model for the investigation of thyroid cancer.
    Gyory F; Mezosi E; Szakall S; Bajnok L; Varga E; Borbely A; Gazdag A; Juhasz I; Lukacs G; Nagy EV
    Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):359-64. PubMed ID: 16025395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy.
    Subhash VV; Yeo MS; Tan WL; Yong WP
    J Immunol Res; 2015; 2015():308574. PubMed ID: 26579545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor microenvironment in thyroid cancer: Immune cells, patterns, and novel treatments.
    Febrero B; Ruiz-Manzanera JJ; Ros-Madrid I; Hernández AM; Orenes-Piñero E; Rodríguez JM
    Head Neck; 2024 Jun; 46(6):1486-1499. PubMed ID: 38380767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.